Login

Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

September 29, 2022
BioUtah News
BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay

FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec today announced their newly developed molecular polymerase chain reaction (PCR) assay for monkeypox virus is now commercially available globally, including in the United States, for research use only applications by laboratories. […]

September 29, 2022
BioUtah News
BioHive Women in STEM Event recap

BioHive continued its celebration of “STEM September” with the Women in STEM Mingle in downtown Salt Lake City on Tuesday night. Over 65 life science professionals were in attendance to connect with the industry and support the efforts of BioHive.  As a collective, event attendees assembled and packed over 475 Math Learning Kits for Granite […]

September 29, 2022
BioUtah News
2022 Biosphere Magazine Now Available

Each year, BioUtah publishes a special Utah life sciences magazine, Biosphere, released with the September issue of Utah Business Magazine. The 2022 iteration of Biosphere focuses on the incredible innovation taking place within Utah’s life sciences industry.  From Intermountain’s evolution beyond health care delivery to become a life sciences powerhouse within Utah to innovation happening within […]

September 29, 2022
BioUtah News
Excess Equipment Sale for BioUtah Members

Excess Equipment Sale for BioUtah Members

September 29, 2022
BioUtah News
FDA Clears Xenocor’s Saberscope, the World’s First Single-use 5mm Laparoscope with Auto-Focus

FDA Clears World’s First Single-use 5mm Laparoscope with Auto-Focus

September 29, 2022
BioUtah News
Merit Medical Launches the TEMNO Elite™ Soft Tissue Biopsy System

Advanced device offers 72% larger samples, simplifies tissue retrieval, and enhances patient safety

September 27, 2022
BioUtah News
AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy

The European Commission’s approval of a novel gene therapy for severe hemophilia A has paved the way for use of a companion diagnostic in the European Union (EU).

September 22, 2022
BioUtah News
Dynatronics Corporation Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Business Highlights

Dynatronics reported financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided an update on recent business highlights.

September 15, 2022
BioUtah News
Recruitment for Non-Invasive Parkinson’s Pivotal Study Slated for December

Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements for patients. The maker of the widely anticipated Celeste® specialized phototherapy device, PhotoPharmics, today announced plans to begin recruitment for the Celeste Light for PD trial in December. “Multiple forces have aligned to make the timing for […]

September 15, 2022
BioUtah News
nView s1 reaches its 100th surgery

The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at six leading pediatric facilities, including three of the top 10 facilities in the nation.

September 15, 2022
BioUtah News
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL

Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.

September 8, 2022
BioUtah News
Inherent Biosciences raises Series A funding led by Propel Bio Partners to redefine the path to parenthood by elevating the standard of care in male reproductive health

Salt Lake City, Utah /PRNewswire/ — Inherent Biosciences, the first Utah company involved in commercializing a diagnostic in the emerging biotech field of epigenetics, has raised Series A funding from an investor group led by Los Angeles-based Propel Bio Partners toward Inherent’s goal of changing the course of reproductive health. Inherent seeks to redefine the […]

September 8, 2022
BioUtah News
BIOHIVE STEM SEPTEMBER KICK-0FF

Last week, BioHive kicked off its celebration of “STEM September” with an evening of networking in downtown Salt Lake City. Life sciences professionals joined from all over the Salt Lake Valley to connect with the industry and support the efforts of BioHive. “I was so inspired hearing stories from the people that make Utah’s life […]

September 8, 2022
BioUtah News Industry News Life Sciences Industry News
Rep. Burgess Owens Spends a Day in the BioHive

Utah life sciences companies took center stage September 2, as U.S. Representative Burgess Owens (R-UT) toured Canyon Labs, Ultradent (Canyon Labs’ parent company), Ortho Development and Xenter – all innovative leaders in advancing medical technologies that improve patient care and provide jobs for hundreds of Utahns. BioUtah helped to facilitate the BioHive day. “Utah is […]

September 1, 2022
BioUtah News
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient

New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications Fluidx Medical announces completion of trial enrollment for its novel embolic device, GPX. In this multi-center trial, GPX was used to treat a variety of primary and metastatic tumors, renal adenoma tumors, and a range […]

August 18, 2022
Policy News
Senator Mike Lee Spends a Day in the BioHive

U.S. Senator Mike Lee (R-UT) on August 15 spent the day connecting with Utah’s life sciences community, known as the BioHive, touring facilities at BD, IONIQ Sciences, SEEK Labs and Carterra. His schedule also included a tour of Altitude Lab in the University of Utah’s Research Park where he led a roundtable discussion with nearly […]

August 18, 2022
BioUtah News
Senator Mike Lee Spends a Day in the BioHive

U.S. Senator Mike Lee (R-UT) on August 15 spent the day connecting with Utah’s life sciences community, known as the BioHive, touring facilities at BD, IONIQ Sciences, SEEK Labs and Carterra. His schedule also included a tour of Altitude Lab in the University of Utah’s Research Park where he led a roundtable discussion with nearly […]

August 17, 2022
BioUtah News
Halia Therapeutics Promotes Targeting the NLRP3 Inflammasome for Alzheimer’s Disease Treatment

Halia Therapeutics, the first biotechnology company to target NEK7 to block the assembly of the NLRP3 inflammasome complex, participated today in a fireside chat exploring approaches to innovate Alzheimer’s therapies at InformaConnect’s Therapeutic Focus-Neurology digital conference. “There is very little help available for people suffering from neuroinflammatory diseases, such as Alzheimer’s (AD). We do know […]

August 17, 2022
BioUtah News
Renalytix Business Update

Based on recently secured private payer and Medicaid insurance coverage contracts for KidneyIntelX, Renalytix plc is disclosing that the upper Midwest region of the United States, and specifically Illinois and Iowa, are now primary commercial expansion markets.  Private insurance coverage contracts secured and effective during the quarter ending September 30, 2022 include Blue Cross Blue […]

August 17, 2022
BioUtah News
Nomi Health Adds Access to Novavax COVID Vaccine in Utah

Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, has expanded its COVID vaccine services with the addition of the Novavax vaccine, now available at the West Valley Nomi Health location. In addition to Novavax, this location also distributes Pfizer, Moderna and Johnson & Johnson vaccines. All […]

August 17, 2022
BioUtah News
Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform Granted by the U.S. Patent Office

Transit Scientific, a Utah-based medical device company, today announced additional U.S. patent protection has been issued from the United States Patent and Trademark Office (USPTO) for its XO exoskeleton sheath platform. Traditional PTA cutting, scoring, and constraining structure (CS) technologies are manufactured with metal or polymer wires, struts, blades, or grooves wrapped around, or fused to, the outside of the angioplasty balloon. These […]

August 11, 2022
BioUtah News
Senate Passes Inflation Reduction Act – Sens. Lee, Romney Oppose

After an all-night session, the Senate on Sunday passed a sweeping, $740 billion reconciliation package titled the “Inflation Reduction.” The measure passed on a party line 51-50 vote, with Vice President Kamala Harris breaking the tie vote. The 755-page bill will now be taken up by the House today, where it is expected to pass […]

August 11, 2022
BioUtah News
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelX™ with Primary Care Physicians

98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b. Published study complements KidneyIntelX clinical utility data published at American Diabetes Association Annual Conference demonstrating improvements in guideline recommended care, including therapeutic managements and specialist consultation […]

August 11, 2022
BioUtah News
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia 

Sumitomo Pharma Oncology, Inc., a clinical-stage company focused on novel cancer therapeutics has announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336, an investigational small molecule inhibitor against the binding of menin and mixed-lineage leukemia (MLL) protein, for the treatment of acute myeloid leukemia (AML).  “We are pleased to have […]